Literature DB >> 1437309

Immunocytochemical detection of megakaryocytes by endothelial markers: a comparative study.

P Calapso1, E Vitarelli, C Crisafulli, G Tuccari.   

Abstract

By endothelial markers such as FVIII, UEA-I, CD31 and QBEND/10, the Authors have investigated the immunohistochemical pattern of bone marrow megakaryocytes in myelodysplastic (8 cases) and myeloproliferative (35 cases) disorders as well as in control biopsies (8 cases). An evident cytoplasmic positivity with FVIII and UEA-I was encountered in all normal and pathological specimens, whereas the immunolocalization of CD31 was limited to megakaryocytes present in normal bone marrow biopsies or in cases of myelofibrosis. No immunostaining with QBEND/10 was observed in any case, although the most selective staining of endothelial cells of bone marrow vessels was noted with this antibody. The usefulness to utilize endothelial markers in order to identify atypical and immature forms of megakaryocytes as well as micromegakaryocytes, especially in myelofibrosis by the aid of CD31, was also discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1437309

Source DB:  PubMed          Journal:  Pathologica        ISSN: 0031-2983


  3 in total

1.  Novel lysyl oxidase inhibitors attenuate hallmarks of primary myelofibrosis in mice.

Authors:  Orly Leiva; Seng Kah Ng; Shinobu Matsuura; Vipul Chitalia; Hector Lucero; Alison Findlay; Craig Turner; Wolfgang Jarolimek; Katya Ravid
Journal:  Int J Hematol       Date:  2019-10-21       Impact factor: 2.490

2.  Megakaryoblastic leukemia presenting as pancytopenia and extensive myelofibrosis in a child diagnosed by myeloid markers and CD 31.

Authors:  Urmila Majhi; Kanchan Murhekar; Shirley Sundersingh; K R Rajalekshmi
Journal:  Indian J Med Paediatr Oncol       Date:  2012-01

3.  An Unusual Case of Myeloperoxidase-Positive Acute Megakaryoblastic Leukemia.

Authors:  Hyeyoung Lee; Yonggoo Kim; Yoo-Jin Kim; Kyungja Han
Journal:  Ann Lab Med       Date:  2015-05-21       Impact factor: 3.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.